Podcast Episode Details
Back to Podcast Episodes
Q&A with Oncimmune CEO, Martin Gouldstone
Episode 1824
In this interview, CEO Martin Gouldstone of Oncimmune - a leading life sciences firm offering autoantibody profiling that is used to enable precision medicine within the Biopharma industry.
00:00 What the company does and the current demand picture within the Biopharma sector
09:15 recent contract wins and update on commercialisation strategy
00:00 What the company does and the current demand picture within the Biopharma sector
09:15 recent contract wins and update on commercialisation strategy
Published on 1 year, 9 months ago